The global surgical stapling devices market size was valued at USD 4.88 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 9.33% from 2023 to 2030. The market is expected to exhibit lucrative growth opportunities in the coming years owing to the increasing preference for staples over sutures. With technological advances, several market players are commercializing staplers used for endoscopic surgeries. These devices find applications across various branches of medicine, such as gynecology, thoracic, and gastrointestinal-related surgeries as well as tissue & wound management procedures. The demand for surgical stapling is expected to increase owing to the rise in bariatric procedures and implementation of advanced technology to perform endoscopic procedures. In addition, the introduction of powered surgical devices and growing need for tissue & wound management would further support the market growth and acceptance of surgical staplers.
Initially, sutures were widely used for wound closure surgeries. However, the introduction of staples has gradually outpaced the suture market due to the several advantages. Apart from being a tedious process, sutured sites may exhibit wound leakage and separation, whereas surgical staplers offer better speed, accuracy, and efficient wound closure.
With technological advancements, several market players are commercializing staplers used for endoscopic surgeries. These devices find application across various branches of medicine, such as gynaecology, thoracic, gastrointestinal-related surgeries, and tissue & wound management procedures.
Moreover, in developing countries, such as India and China, surgical staplers are widely used for bariatric surgeries. Covidien plc and Ethicon Endo-Surgery, Inc. offering titanium stomach staples, reported that obesity-related surgeries in India have doubled in 2013, and hence, the number of bariatric procedures has increased in the country.
Manual surgical staplers were used along with scalpels, forceps, and scissors. With rising demand and increasing frequency of surgeries, powered stapling devices are expected to be the fastest growing product segment over the forecast period. These powered surgical staplers address the problem of fatigue in doctors due to the high procedure volume in hospital emergency wards. Thus, such benefits offered by manual surgical staplers is anticipated to foster the segment growth.
The major advantage offered by powered stapling involves the ease of wound closure without the need of manual firing force. The powered surgical stapling devices are available in various sizes that offer medical practitioners greater choice when choosing a circular stapling or powered linear system to perform complex surgical procedures. Increasing adoption of powered surgical stapling devices is predicted to propel market growth.
Based on the type of material used, there are two major types: disposable and reusable. The disposable segment is expected to grow at a rapid rate over the forecast period as a result of heightened concerns over communicable infections. The Centers for Disease Control and Prevention (CDC) promotes the use of disposable devices including disposable surgical stapling devices and provides protocols to prevent the spread of pathogens. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) have also stated some measures to ensure that set protocols for the sterilization of medical devices are strictly followed in order to avoid infections.
Reusable segment held significant market share in 2022. Reusable surgical stapling devices can be used on several patients after sterilization process. Introduction of surgical stapling devices along with absorbable staplers is estimated to fuel the segment growth during the forecast period. High cost associated with reusable stapling devices is predicted to impede the segment growth.
The End-use segment for the surgical stapling devices market is bifurcated into hospitals and ambulatory centers. Hospitals segment was identified as the largest end-use segment in the year 2022 whereas, ambulatory centres segment is anticipated to display the highest growth over the forecast period. The steady growth of the ambulatory centers segment can be attributed to factors such as scarce economic resources and the shortage of hospital beds, especially in underdeveloped and developing economies.
A major trend in hospitals suggests a shift toward clinical efficiency models, which includes the introduction of robotic technology in surgery. Robotic surgeries improve the outcome of minimally invasive surgeries. The hospitals segment is expected to retain its dominance over the forecast period owing to favourable reimbursement scenario for various surgeries.
North America held the largest market share owing to the use of advanced technologies and non-invasive methods in the increasing number of total surgeries performed. Other reasons for huge market share are the highest obesity rate in this region, the local presence of global players, and FDA approval for non-invasive surgeries. With recent developments in minimally invasive surgeries, special devices are designed for laparoscopic and thoracoscopic surgeries, which includes the use of surgical stapling. It has become the responsibility of surgeons to acquire the prerequisite knowledge of stapling devices
Asia Pacific is the fastest growing market with a CAGR of over 9.74% due to the presence of a large patient pool in economies such as India, China, and Japan. With an increasing conduct of surgical procedures, coupled with the rising healthcare expenditure, and an increasing awareness, the demand for stapling is expected to witness a lucrative growth. Key players in the industry are also investing in this region to expand their footprints. Initiatives such as those taken by Johnson & Johnson Medical, India, to train 8,000 doctors in advanced surgical products, including non-invasive surgical staples, are expected to propel the growth of the surgical stapling devices market in the region.
Several key industry contributors are focusing on developing advanced surgical stapling devices to expand their market reach. For instance, in June 2022, Ethicon announced the launch of ECHELON 3000 Stapler for surgeons in the U.S. Market players are also focusing on strategic growth initiatives to strengthen their market presence. Some of the key players operating in the global surgical stapling devices market are:
Covidien
Ethicon US., LLC
Intuitive Surgical
Cardica, Inc.
Stryker
Smith & Nephew
CONMED Corporation
CareFusion Corporation
3M Healthcare
BioPro, Inc.
Report Attribute |
Details |
Market size value in 2023 |
USD 5.30 billion |
Revenue forecast in 2030 |
USD 9.89 billion |
Growth rate |
CAGR of 9.33% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2023 to 2030 |
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors & trends |
Segments covered |
Product, type, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Norway; Sweden; Denmark; Japan; China; India; South Korea; Australia; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; Kuwait; UAE |
Key companies profiled |
HAAG-STREIT GROUP; Olympus Corp.; Leica Microsystems; B. Braun Melsungen Inc.; Accurate Surgical & Scientific Instruments Corp.; Surtex Instruments Ltd.; Scanlan International; Carl Zeiss AG; KLS Martin Group; Topcon Corp.; Integra LifeSciences |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub segments from 2018 to 2030. For this study, Grand View Research has segmented the surgical stapling devices market report based on product, type, end-use, and region:
Product Outlook (Revenue, USD Million; 2018 - 2030)
Powered
Manual
Type Outlook (Revenue, USD Million; 2018 - 2030)
Disposable
Reusable
End-use Outlook (Revenue, USD Million; 2018 - 2030)
Hospitals
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Europe
France
Germany
U.K.
Spain
Italy
Norway
Sweden
Denmark
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
UAE
Saudi Arabia
Kuwait
b. The global surgical stapling devices market size was estimated at USD 4.88 billion in 2022 and is expected to reach USD 5.30 billion in 2023.
b. The global surgical stapling devices market is expected to grow at a compound annual growth rate of 9.33% from 2023 to 2030 to reach USD 9.89 billion by 2030.
b. North America dominated the surgical stapling devices market with a share of 29.8% in 2022. This is attributable to the use of advanced technologies and non-invasive methods in increasing the number of total surgeries performed.
b. Some key players operating in the surgical stapling devices market include Covidien plc; Ethicon Endo-Surgery, Inc.; Cardica, Inc.; Zimmer Holdings, Inc.; Stryker Corporation; Smith & Nephew plc; Conmed Corporation; and CareFusion Corporation.
b. Key factors that are driving the surgical stapling devices market growth include the increasing need for wound and tissue management devices, the introduction of advanced technologies, increasing demand for minimally invasive surgery and robotic surgery, increasing obesity and awareness about bariatric surgeries, and increasing incidence rate of cancer.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.
We value your investment and offer free customization with every report to fulfil your exact research needs.